Oryx Int. Growth Fnd - Director/PDMR Shareholding

Oryx International Growth Fund

12/10/2026 14:44

RNS Number : 6073Y
  
Oryx International Growth Fund Ld
  
12 October 2026
  
 


12 October 2026
 
Oryx International Growth Fund Limited
(the "Company") 
 
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
 
On 9 October 2026, North Atlantic Smaller Companies Investment Trust plc, an entity closely associated with Mr Christopher Mills (Director of the Company), purchased 133,500 shares in the Company.
The below notification, made in accordance with the requirements of article 19.3 of the UK Market Abuse Regulation, gives further details:




1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)


Name


1)    Christopher Mills
2)    North Atlantic Smaller Companies Investment Trust Plc




2


Reason for the notification




a)
 


Position/status


1)    Director
2)    PCA




b)
 


Initial notification /Amendment
 


Initial Notification




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)
 


Name
 


Oryx International Growth Fund Limited




b)
 


LEI
 


213800W5W6THP34TW941




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)
 


Description of the financial instrument, type of instrument
 
Identification code


 
Ordinary Shares
 
SEDOL : B3BTVQ9
 




b)
 


Nature of the transaction


Purchase




c)
 


Price(s) and volume(s)
 
 


 




Price(s)
 


Volume(s)




1354.1329p


133,500









d)
 


Aggregated information
- Aggregated volume
- Price per share
 


 
133,500
£13.541329




e)
 


Date of the transaction
 


9 October 2026




f)


Place of the transaction


London Stock Exchange (XLON)




 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHBXBDGBSBDGLD